Catalyst Wire Dossier Catalyst Wire Dossier

Telbivudine (Tyzeka)

telbivudine · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Telbivudine (Tyzeka), covering 2009-10-14 to 2013-10-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of Telbivudine in Chronic Hepatitis B Patients

See pricing